Indian Journal of Drugs in Dermatology

CASE REPORT
Year
: 2022  |  Volume : 8  |  Issue : 1  |  Page : 29--31

Topical 5-fluorouracil for Basal Cell Carcinoma


Anil Balkrishna Bhokare 
 Apex skin clinic, Malegaon, Dist-Nashik, Maharashtra, India

Correspondence Address:
Anil Balkrishna Bhokare
Apex skin clinic, Malegaon, Dist-Nashik 423203, Maharashtra
India

Basal cell carcinoma is a malignant epithelial tumor arising only in skin, from the basal layer of the epidermis or of the pilosebaceous adnexa. Diagnosis often depends on skin examination, confirmed by tissue biopsy. Treatment is typically by surgical removal. This can be by simple excision if the cancer is small; otherwise Mohs surgery is generally recommended. Other options may include topical chemotherapy, laser therapy, or the use of imiquimod. In this study, we conclude topical 5-fluorouracil is a highly effective and well-tolerated treatment option for superficial basal cell carcinomas.


How to cite this article:
Bhokare AB. Topical 5-fluorouracil for Basal Cell Carcinoma.Indian J Drugs Dermatol 2022;8:29-31


How to cite this URL:
Bhokare AB. Topical 5-fluorouracil for Basal Cell Carcinoma. Indian J Drugs Dermatol [serial online] 2022 [cited 2022 Nov 27 ];8:29-31
Available from: https://www.ijdd.in/article.asp?issn=2455-3972;year=2022;volume=8;issue=1;spage=29;epage=31;aulast=Bhokare;type=0